1.Prevention and Treatment for Pressure Ulcer (review)
Shengying CHENG ; Linjin RAN ; Lamei LIU ; Yunfang TU ; Yuan ZENG
Chinese Journal of Rehabilitation Theory and Practice 2015;(11):1290-1293
Pressure ulcer is a kind of cutaneous and subcutaneous exelcosis and necrosis as suffered long-term pressure. Pressure ulcer mainly related with age, long-term in bed, chronic diseases, lower resistibility, vasculitis and less activities, as well as long-term pressing, poor blood circulation and untidy body environment. Pressure ulcer can be classified into 4 stages with severity. The risk to pressure ulcer should be evaluated, mainly with Braden score. Prevention of pressure ulcer included keeping clean, avoiding long-term pressure and find-ing potential pressure ulcer as soon as possible, based on improving the system situation and dealing with original diseases. For the patients suffered from pressure ulcer, it was important to decompress, debride the wound, keep humidity, and apply some new dressing with external drugs and vacuum sealing draining (VSD) and good psychological nurse and communication.
2.Stimulation of bone marrow fibroblst conditioned medium on megakaryocyte in vitro and platelet in vivo.
Yan-hong HUANG ; Xiao-yin ZHOU ; Men-qun TAN ; Lamei CHENG ; Guangxiu LU ; Qiru WANG
Journal of Central South University(Medical Sciences) 2005;30(6):726-728
Animals
;
Blood Platelets
;
cytology
;
Bone Marrow Cells
;
cytology
;
Cell Differentiation
;
Cells, Cultured
;
Culture Media, Conditioned
;
Cyclophosphamide
;
Female
;
Fibroblasts
;
cytology
;
Male
;
Megakaryocytes
;
cytology
;
Mice
;
Stem Cells
;
cytology
;
Thrombocytopenia
;
chemically induced
;
therapy
3.Therapeutic potential of BMSCs for premature ovarian failure in mice
Jing PENG ; Na XIAO ; Lamei CHENG
Journal of Central South University(Medical Sciences) 2018;43(1):7-13
Objective:To explore the therapeutic effects of bone marrow-derived mesenchymal stem cells (BMSCs) on premature ovarian failure (POF) in mice induced by cyclophosphamide (CTX) and the possible mechanisms.Methods:Mouse BMSCs were identified through detection of cell surface markers by flow cytometry.The model of mouse POF was induced by intraperitoneal injection of CTX at a dose of 50 mg/kg,once daily for 15 days.BMSCs were transplanted into POF mice at 2×106 cells/mouse by tail veil.The ovarian tissues were collected for HE staining at 7 days after transplantation to observe the changes of ovarian structure and real-time PCR was performed to detect the folliculogenesis gene expression.Results:BMSCs showed positive expression of CD29 and CD90 while low expression for endothelial and hematopoietic cell markers CD31 and CD34.The numbers of primodial follicle,primary follicle,secondary follicle and antral follicle were significantly decreased,but the numbers of atretic follicle were significantly increased in CTX induced-POF mice (P<0.05).BMSCs transplantation effectively repaired the structure of damaged ovary.The significant reduction of atretic follicle and significant increase of antral follicle and secondary follicle were observed in ovaries of BMSCs-treated mouse(P<0.05).BMSCs-transplanted mouse ovaries showed the increased mRNA expression levels ofNano3,Nobox,and Lhx8 (P<0.05).Conclusion:BMSCs could effectively repair ovarian structure and promote follicle development in CTX-induced POF mouse.
4.Angiogenic ability of 3 different tissues-derived mesenchymal stem cells on endothelial progenitor cells
Siqi WANG ; Haiyuan LU ; Lamei CHENG
Journal of Central South University(Medical Sciences) 2018;43(2):184-191
Objective:To compare the ability between bone marrow-derived mesenchymal stem cells (MSCs) (BM-MSCs) and adipose-derived MSCs (AD-MSCs) or umbilical cord-derived MSCs (UC-MSCs) on promotion of vessels formation and vessds stabilization relevant to the functions of EPCs.Methods:In vitro,co-culture blood vessel test was performed to compare the angiogenic ability between BM-MSCs,AD-MSCs or UC-MSCs.In vivo,angiogenic assay dependent on basement membrane matrix Matrigel and immunohistochemistry were performed to compare the ability of vessels formation functions between BM-MSCs and AD-MSCs or UC-MSCs.Results:The lengths and dots of vascular structures formed by EPCs on AD-MSCs layer are greater than those by EPCs on BM-MSCs layer and UC-MSCs layer in angiogenic assay in vitro.The stability of the capillary-like structures formed by EPCs with AD-MSCs on Matrigel was more stable than that by the BM-MSCs,UC-MSCs or EPCs.AD-MSCs and EPCs could form abundant functional vessels with blood perfusion in Matrigelin vivo;UC-MSCs and EPCs could form a few functional vessels with blood perfusion in Matrigelin vivo;BM-MSCs and EPCs could form broken vessels with hemocytes leakage in Matrigel in vivo.Conclusion:AD-MSCs have the stronger ability to promote the angiogenesis and stabilize the vessels compared with BM-MSCs or UC-MSCs ex vivo and in vivo.
5.Optimization of chromosome flaking technique for mesenchymal stem cells.
Maosheng CHEN ; Chuang LI ; Dehua CHENG ; Yueqiu TAN ; Hua MEI ; Siqi WANG ; Xiang LI ; Lamei CHENG
Chinese Journal of Medical Genetics 2019;36(2):143-146
OBJECTIVE:
To optimize the condition for chromosome flaking of mesenchymal stem cells to ensure the cytogenetic quality control of expanding production and clinical application.
METHODS:
Chromosomal flaking methods were optimized from current chromosome preparation techniques from the aspects of MSCs cell culture concentration, colchicine treatment time and low permeability time.
RESULTS:
By repeated pre-experiments, the optimal MSCS chromosome flaking condition of MSCs was determined as cell culture concentration of (1-2)× 10 cells per T25 cell culture bottle, and the colchicines processing time was determined as 2 hours and 10 minutes, and the low permeability was 1 hour.
CONCLUSION
The optimized chromosome flaking condition can fulfill the requirement of cytogenetic quality control for MSCs.
Cell Culture Techniques
;
Cell Differentiation
;
Cells, Cultured
;
Chromosome Disorders
;
Chromosomes, Human
;
Cytogenetics
;
Humans
;
Mesenchymal Stem Cells
6.The study of characteristic of serum Lp(a)level in in patients with chronic kidney disease
Qijian HUANG ; Jin ZHANG ; Decai QIAN ; Hongfu ZHANG ; Liang CHEN ; Yajie WANG ; Qiang WANG ; Lamei LIAO ; Yusong LIU ; Rulan CHENG ; Weijun ZHAO ; Jihong LIU ; Sheng LUO ; Jun ZHENG ; Jun LIU ; Fangfang LI ; Jianping HUANG
Chinese Journal of Primary Medicine and Pharmacy 2017;24(2):161-164
Objective To investigate the characteristic of lipoprotein(a)[Lp(a)]in different phases of chronic kidney disease (CKD ),to provide the basis for clinical prevention and treatment of CKD.Methods 200 patients with CKD in the Republic Hospital of Shifang were collected as study group,including 5 phases (every phase had 40 cases),and 100 healthy people were selected as control group.Measured the serum Lp(a)of both study and control group,analyzed the correlations between Lp(a)and different phase of CKD.All data were analyzed by SPSS version 17.0.The significant level was established at 0.05.Results CKD1 [(146.0 ±95.5)mg/L]and all CKD group [(231.5 ±133.2)mg/L]had higher level of serum Lp(a)than the control group [(115.5 ±70.2)mg/L] (Z=-2.800,P<0.05 and Z=-7.922,P<0.05).CKD3 had higher Lp(a)level than CKD2(Z=-2.069,P<0.05 ),while there were no significant differences between each of the other two groups.CKD4 -5 [(325 .0 ± 194.7)mg/L]also had higher Lp(a)level than CKD1 -3 [(182.0 ±110.5)mg/L](Z=-4.439,P<0.05). Conclusion Patients with CKD always have high level of serum Lp(a),which have been slowly increased since CKD1 ,meanwhile the level of Lp(a)may have a certain correlation with the stage of CKD development,since Lp(a) is an important promoting factor in the progress of CKD.
7.Umbilical Cord Mesenchymal Stem Cells for Inhibiting the Fibrosis and Autoimmune Development in HOCl-Induced Systemic Scleroderma Mouse Model
Xin JIN ; Jiali HOU ; Ke ZHENG ; Dan WEI ; Ali ZHANG ; Siqi WANG ; Hua MEI ; Chuang LI ; Lamei CHENG ; Xuan SUN
International Journal of Stem Cells 2021;14(3):262-274
Background and Objectives:
Systemic scleroderma (SSc) is a rare and serious connective tissue disease, an autoimmune disease, and a rare refractory disease. In this study, preventive effect of single systemic human umbilical cord mesenchymal stem cells (UC-MSCs) transfusion on SSc was preliminarily explored.
Methods:
and Results: SSc mouse model was established by daily intradermal injection of Hypochlorite (HOCl). SSc mice were treated by single transfusion of UC-MSCs at 0.625×10 5 , 2.5×105 and 1×106 respectively. At the 42nd day of intradermal injection of HOCl, the symptoms showed up by skin and alveolar wall thickening, lymphocytic infiltration, increased collagen in skin/lung, and the increased proportion of CD3 + CD4+ CD25+ FoxP3+ cells (a Treg subset) in spleen. After UC-MSCs transfusion, the degree of skin thickening, alveolar wall thickening and lymphocyte infiltration were decreased, the collagen sedimentation in skin/lung was decreased, and the proportion of CD3+ CD4+ CD25+FoxP3+ cells was decreased.
Conclusions
UC-MSC can achieve a preventive effect in SSc mice by fibrosis attenuation and immunoregulation.
8.Umbilical Cord Mesenchymal Stem Cells for Inhibiting the Fibrosis and Autoimmune Development in HOCl-Induced Systemic Scleroderma Mouse Model
Xin JIN ; Jiali HOU ; Ke ZHENG ; Dan WEI ; Ali ZHANG ; Siqi WANG ; Hua MEI ; Chuang LI ; Lamei CHENG ; Xuan SUN
International Journal of Stem Cells 2021;14(3):262-274
Background and Objectives:
Systemic scleroderma (SSc) is a rare and serious connective tissue disease, an autoimmune disease, and a rare refractory disease. In this study, preventive effect of single systemic human umbilical cord mesenchymal stem cells (UC-MSCs) transfusion on SSc was preliminarily explored.
Methods:
and Results: SSc mouse model was established by daily intradermal injection of Hypochlorite (HOCl). SSc mice were treated by single transfusion of UC-MSCs at 0.625×10 5 , 2.5×105 and 1×106 respectively. At the 42nd day of intradermal injection of HOCl, the symptoms showed up by skin and alveolar wall thickening, lymphocytic infiltration, increased collagen in skin/lung, and the increased proportion of CD3 + CD4+ CD25+ FoxP3+ cells (a Treg subset) in spleen. After UC-MSCs transfusion, the degree of skin thickening, alveolar wall thickening and lymphocyte infiltration were decreased, the collagen sedimentation in skin/lung was decreased, and the proportion of CD3+ CD4+ CD25+FoxP3+ cells was decreased.
Conclusions
UC-MSC can achieve a preventive effect in SSc mice by fibrosis attenuation and immunoregulation.